173 related articles for article (PubMed ID: 23922113)
1. High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients.
Itakura M; Terashima Y; Shingyoji M; Yokoi S; Ohira M; Kageyama H; Matui Y; Yoshida Y; Ashinuma H; Moriya Y; Tamura H; Harigaya K; Matushima K; Iizasa T; Nakagawara A; Kimura H
Br J Cancer; 2013 Sep; 109(5):1100-8. PubMed ID: 23922113
[TBL] [Abstract][Full Text] [Related]
2. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Yang X
Med Oncol; 2015 Mar; 32(3):47. PubMed ID: 25636509
[TBL] [Abstract][Full Text] [Related]
3. An assessment of the relationship between the expression of CCR7/CCL19 axis and selected regulatory miRNAs in non-small cell lung cancer.
Baran K; Kiszałkiewicz J; Migdalska-Sęk M; Jabłoński S; Kordiak J; Antczak A; Góralska K; Brzeziańska-Lasota E
Mol Biol Rep; 2019 Oct; 46(5):5389-5396. PubMed ID: 31463641
[TBL] [Abstract][Full Text] [Related]
4. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.
Shi JY; Yang LX; Wang ZC; Wang LY; Zhou J; Wang XY; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Tang QQ; Gao Q; Fan J
J Pathol; 2015 Mar; 235(4):546-58. PubMed ID: 25255875
[TBL] [Abstract][Full Text] [Related]
5. Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.
Cheung HW; Du J; Boehm JS; He F; Weir BA; Wang X; Butaney M; Sequist LV; Luo B; Engelman JA; Root DE; Meyerson M; Golub TR; Jänne PA; Hahn WC
Cancer Discov; 2011 Dec; 1(7):608-25. PubMed ID: 22586683
[TBL] [Abstract][Full Text] [Related]
6. Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.
Ma R; Guan X; Teng N; Du Y; Ou S; Li X
BMC Med Genomics; 2023 Oct; 16(1):254. PubMed ID: 37864213
[TBL] [Abstract][Full Text] [Related]
7. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
[TBL] [Abstract][Full Text] [Related]
8. BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations.
Karachaliou N; Costa C; Gimenez-Capitan A; Molina-Vila MA; Bertran-Alamillo J; Mayo C; Massuti B; Majem M; Carcereny E; Moran T; Sanchez JJ; Viteri S; Gasco A; Wannesson L; Souglakos J; Jimeno J; Rosell R;
J Thorac Oncol; 2013 Mar; 8(3):295-300. PubMed ID: 23407556
[TBL] [Abstract][Full Text] [Related]
9. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
10. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
[TBL] [Abstract][Full Text] [Related]
11. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.
Maekawa S; Iwasaki A; Shirakusa T; Kawakami T; Yanagisawa J; Tanaka T; Shibaguchi H; Kinugasa T; Kuroki M; Kuroki M
Oncol Rep; 2008 Jun; 19(6):1461-8. PubMed ID: 18497951
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma.
Liu DH; Zhao ZR; Lin YB; Zhou WJ; Hou JY; Ye ZH; Long H
Ann Surg Oncol; 2019 Jun; 26(6):1934-1941. PubMed ID: 30820786
[TBL] [Abstract][Full Text] [Related]
13. [Chemokine receptor 7 induces metastasis of NSCLC via upregulating MMP-9 expression].
Li Y; Liu W; Fang L; Nan J; Zhang Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1016-20. PubMed ID: 21081040
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
Xia Y; Liu L; Xiong Y; Bai Q; Wang J; Xi W; Qu Y; Xu J; Guo J
BMC Cancer; 2017 Jan; 17(1):70. PubMed ID: 28114889
[TBL] [Abstract][Full Text] [Related]
15. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
[TBL] [Abstract][Full Text] [Related]
16. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.
Oliveira-Neto HH; de Souza PP; da Silva MR; Mendonça EF; Silva TA; Batista AC
Tumour Biol; 2013 Feb; 34(1):65-70. PubMed ID: 22976543
[TBL] [Abstract][Full Text] [Related]
17. CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation.
Suda K; Mizuuchi H; Murakami I; Uramoto H; Tanaka F; Sato K; Takemoto T; Iwasaki T; Sekido Y; Yatabe Y; Mitsudomi T
Lung Cancer; 2014 Aug; 85(2):147-51. PubMed ID: 24939008
[TBL] [Abstract][Full Text] [Related]
18. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
19. CRKL as a lung cancer oncogene and mediator of acquired resistance to EGFR inhibitors: is it all that it is cracked up to be?
Ladanyi M
Cancer Discov; 2011 Dec; 1(7):560-1. PubMed ID: 22211192
[TBL] [Abstract][Full Text] [Related]
20. Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.
Lee JG; Kim S; Shim HS
Lung Cancer; 2012 Jul; 77(1):156-61. PubMed ID: 22418245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]